The mGlu4 receptors are also potential drug targets for neuroprotection in ischemic stroke as shown by the evidence that mGlu4 receptor activation reduced infarct size in ischemic mice and rats, whereas brain damage was amplified in mGlu4−/− mice (40). This evidence concerns the gene GRM4 and ischemic stroke.